Lion Biotechnologies Inc Share Price OTC Bulletin Board
Equities
LBIO
US53619R1023
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 161M 12.87B | Sales 2025 * | 413M 32.92B | Capitalization | 3.81B 304B |
---|---|---|---|---|---|
Net income 2024 * | -352M -28.06B | Net income 2025 * | -245M -19.53B | EV / Sales 2024 * | 22.8 x |
Net cash position 2024 * | 133M 10.63B | Net cash position 2025 * | 251M 19.97B | EV / Sales 2025 * | 8.63 x |
P/E ratio 2024 * |
-10.5
x | P/E ratio 2025 * |
-18.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.92% |
Latest transcript on Lion Biotechnologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Frederick Vogt
CEO | Chief Executive Officer | 50 | 29/09/16 |
Director of Finance/CFO | 51 | 13/12/20 | |
Brian Shew
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Merrill McPeak
BRD | Director/Board Member | 88 | 19/07/11 |
Director/Board Member | 56 | 06/06/16 | |
Michael Weiser
BRD | Director/Board Member | 61 | 14/03/18 |
1st Jan change | Capi. | |
---|---|---|
-16.10% | 11.41B | |
-30.20% | 2.3B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- IOVA Stock
- LBIO Stock